Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody-Reference-Cited by-同舟云学术

Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody

Published:2018-12-28 Issue:12 Volume:13 Page:e0209509
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sampei Zenjiro^ORCID,Haraya Kenta,Tachibana Tatsuhiko,Fukuzawa Taku,Shida-Kawazoe Meiri,Gan Siok Wan,Shimizu Yuichiro,Ruike Yoshinao,Feng Shu,Kuramochi Taichi,Muraoka Masaru,Kitazawa Takehisa,Kawabe Yoshiki^ORCID,Igawa Tomoyuki,Hattori Kunihiro,Nezu Junichi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Engineering the variable region of therapeutic IgG antibodies;T Igawa;MAbs,2011

2. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates;KJ Vincent;Biotechnol J,2012

3. Engineering antibody therapeutics;ML Chiu;Curr Opin Struct Biol,2016

4. Advances in therapeutic Fc engineering—modulation of IgG-associated effector functions and serum half-life;A Saxena;Front Immunol,2016

5. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria;P Hillmen;N Engl J Med,2006

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement‐targeted therapeutics: Are we there yet, or just getting started?;European Journal of Immunology;2024-09-12

2. Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling;Structure;2024-09

3. Crovalimab: First Approval;Drugs;2024-05-14

4. MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells;Molecular Cancer Therapeutics;2024-04-26

5. AviTrap: A novel solution to achieve complete biotinylation;PLOS ONE;2024-04-25